Readmission From Skilled Nursing Facility Often Avoidable

Share this content:
Readmission From Skilled Nursing Facility Often Avoidable
Readmission From Skilled Nursing Facility Often Avoidable

THURSDAY, Dec. 22, 2016 (HealthDay News) -- A considerable proportion of hospital readmissions from skilled nursing facilities (SNFs) are considered potentially avoidable, according to a study published online Dec. 16 in the Journal of the American Geriatrics Society.

Eduard E. Vasilevskis, M.D., M.P.H., from the Vanderbilt University Medical Center in Nashville, Tenn., and colleagues performed a prospective cohort study to examine the percentage of readmissions from post-acute care that are considered potentially avoidable from hospital and SNF perspectives. Patients from a quality improvement trial who were discharged to one of 23 regional SNFs and readmitted to the hospital within 30 days were enrolled.

The researchers found that there were 262 hospital readmissions among 1,808 discharges, for a 30-day unplanned readmission rate to the index hospital of 14.5 percent. One hundred twenty of the readmissions had root-cause analyses from both the hospital and SNF. Thirty and 13.3 percent of readmissions were rated as potentially avoidable according to hospital and SNF staff, respectively. For 73.3 percent of the 120 readmissions, hospital and SNF ratings of potential avoidability agreed; readmission factors varied between settings. The most common avoidable readmission factors by hospitals and SNFs were diagnostic problems and improved management of changes in conditions, respectively.

"These data support the need for joint accountability and collaboration for future readmission reduction efforts between hospitals and their SNF partners," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »